Professor

Dr. Mujibur Khan is a Professor in the College of Engineering and Computing at Georgia Southern University whose research focuses on nanotechnology-based drug delivery systems, nanotherapeutic processing, polymer nanocomposites, electrospinning, electrospraying, and translational biomedical engineering applications. His interdisciplinary research integrates engineering, materials science, nanomanufacturing, and bio-nanotechnology to develop advanced nanostructured materials for cancer therapeutics, biomedical devices, environmental remediation, and functional nanocomposites. Dr. Khan received his Ph.D. in Mechanical Engineering from Florida Atlantic University in 2010. Prior to that, he earned a Master of Science degree in Mechatronics from King's College London through the Commonwealth Scholarship Program funded by the United Kingdom Government. He completed his Bachelor of Science degree in Mechanical Engineering from Bangladesh University of Engineering and Technology, one of the leading engineering institutions in South Asia. Before joining Georgia Southern University, Dr. Khan served as a Research Assistant Professor at the University of Texas at El Paso, where he expanded his research in polymer processing, nanocomposite fabrication, and nanotechnology applications. He joined Georgia Southern University in 2012 as an Assistant Professor, was promoted to Associate Professor in 2018, and became Professor in 2026. Over the course of his academic career, he has established a nationally recognized interdisciplinary research program emphasizing scalable nanotherapeutic processing, controlled drug delivery systems, and translational nanomedicine. Dr. Khan’s current research program focuses extensively on targeted cancer therapeutics using biodegradable nanofibers and injectable nanocapsules. His laboratory has successfully developed anticancer drug-loaded nanofibers and polymeric nanocarriers capable of sustained and site-specific drug release without significant burst effects. Using advanced electrospinning and electrospraying technologies, his research group has engineered nanostructured delivery systems for encapsulation of chemotherapeutic agents including 5-fluorouracil (5-FU), paclitaxel, cytarabine, and other therapeutic compounds. His work investigates nanoparticle morphology, encapsulation efficiency, biodistribution, cytotoxicity, and controlled drug release kinetics for precision cancer treatment applications. A major focus of Dr. Khan’s recent research involves the development of targeted nanotherapeutics for aggressive cancers, including breast cancer and Glioblastoma (GBM). His ongoing work seeks to engineer injectable and image-guided nanocapsule systems capable of crossing the blood–brain barrier (BBB) through enhanced permeability and retention (EPR)-based and peptide-mediated receptor targeting approaches. These technologies are designed to improve localized therapeutic efficacy while minimizing systemic toxicity associated with conventional chemotherapy. His translational research has significant potential to improve cancer treatment outcomes through scalable and clinically relevant nanomedicine platforms. In addition to biomedical engineering applications, Dr. Khan has contributed significantly to the development of multifunctional polymer nanocomposites and nanofiber-based membranes for environmental and energy applications. His work on polyacrylonitrile (PAN) nanofibers functionalized with metal–organic framework (MOF) nanoparticles demonstrated enhanced carbon dioxide adsorption performance through scalable electrospinning and electrospraying processes. He also contributed to the development of plasma-treated nanofiber membranes and nanocomposite sensors for piezoelectric and sensing applications. Dr. Khan has authored and co-authored over 75 peer-reviewed journal publications, conference papers and presentations in the areas of nanotechnology, cancer nanomedicine, polymer engineering, advanced manufacturing, and biomedical engineering. His recent publications include studies on anticancer drug nanoparticle synthesis and processing, co-axial electrospraying of injectable multicancer drug nanocapsules, biodistribution analysis of peptide-functionalized nanoparticles, and infrared thermography-based frameworks for additive manufacturing quality monitoring. Dr. Khan has secured and led numerous externally funded research projects from organizations including the National Science Foundation (NSF), Department of Energy (DOE), Georgia CORE Cancer Research, and industrial partners. His funded projects include advanced electrospinning and electrospraying systems, multifunctional composites for vehicle applications, smart sensors for hydrogen storage systems, and nanocapsule-based targeted cancer therapeutics. His research leadership has helped establish advanced nanotechnology infrastructure and interdisciplinary collaborations at Georgia Southern University. Throughout his career, Dr. Khan ha